Glaxo Gains First U.S. Approval This Year in Cancer Drug Push

(Bloomberg) -- GlaxoSmithKline Plc’s ovarian cancer drug Zejula won U.S. approval for use at an earlier stage of treatment, giving thousands more patients access to the therapy to help prevent thei...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.